# AI in Residence at Xaira Therapeutics

> United States · Unspecified · Other · open. Source: https://alderhq.app/jobs/greenhouse%3Axairatherapeutics%3A5089321007 (read 2026-11-07).

## Facts (observed)

- Company: [Xaira Therapeutics](https://alderhq.app/companies/xaira-therapeutics)
- Location text: South San Francisco, California, United States; South San Francisco, CA
- Where it can be done from (inferred): United States (evidence: "Location: South San Francisco, California, United States; South San Francisco, CA")
- Posted: 2026-03-25 (227 days ago)
- First seen by alder: 2026-11-02 · last verified: 2026-11-04
- Reposted: 0 times · edited: 0 times
- Apply on the employer's site: https://job-boards.greenhouse.io/xairatherapeutics/jobs/5089321007
- Skills listed (inferred): LLMs

## Pay and sponsorship

- Posted pay: not posted
- Market band for similar posted roles (SF Bay Area, n 2435): p25 $100k, median $157k, p75 $210k
- H-1B filings at this company for similar roles, FY26: 1 ([US DOL OFLC LCA disclosure data](https://www.dol.gov/agencies/eta/foreign-labor/performance))

## Description (the employer's text)

### About Xaira Therapeutics

Xaira is an innovative biotech startup focused on leveraging AI to transform drug discovery and development. The company is leading the development of generative AI models to design protein and antibody therapeutics, enabling the creation of medicines against historically hard-to-drug molecular targets. It is also developing foundation models for biology and disease to enable better target elucidation and patient stratification. Collectively, these technologies aim to continually enable the identification of novel therapies and to improve success in drug development. Xaira is headquartered in the San Francisco Bay Area, Seattle, and London.

### AI in Residence

AI in Residence is a highly selective role at the intersection of frontier machine learning and drug discovery. Designed as an industry alternative to a traditional postdoctoral position, the program is for exceptional researchers and engineers who want to apply advanced AI to real biomedical problems end to end, from data to deployed systems.

Residents join a small cohort working on high-impact AI efforts across Xaira. You’ll collaborate closely with AI scientists, research engineers, and drug discovery teams to design, build, and ship machine learning capabilities that directly influence therapeutic programs. This is hands-on, system-level work with real scientific consequence.

We’re looking for candidates with technical depth, intellectual independence, strong research judgment, and evidence of delivering high-quality work—whether through publications, open-source, or production systems.

### What You’ll Do

- Develop and advance ML models for biological, preclinical, and translational datasets (e.g., multimodal omics, imaging, text, assay data)
- Design and implement scalable pipelines for data curation, training, evaluation, and inference integrated into discovery workflows
- Own projects end-to-end: problem framing → prototyping → validation → deployment
- Evaluate robustness and reliability (generalization, uncertainty, failure modes), plus interpretability where it supports scientific decision-making
- Contribute technical leadership by proposing new directions, shaping platform capabilities, and raising engineering/research standards through collaboration
### You Might Work On

Examples include (not limited to):

- Foundation / representation models over multimodal biological and translational data
- Methods for small, biased, noisy datasets; distribution shift; and uncertainty estimation
- ML systems for experimental prioritization, assay interpretation, or translational signal discovery
- Evaluation frameworks and benchmarks tailored to discovery decision-making
- Tooling that makes models usable by scientists (interfaces, automation, monitoring)
### What Success Looks Like

- You ship one or more models or pipelines that are used in real discovery workflows
- Your work improves decision quality (e.g., better prioritization, faster iteration, clearer uncertainty)
- You raise the bar on evaluation rigor and reproducibility (strong baselines, error analysis, reliable metrics)
- You leave behind maintainable systems (tests, documentation, monitoring) that others can build on
### We Value

- Strong research judgment: choosing the right problems and knowing what “good evidence” looks like
- Rigor: careful experimental design, ablations, error analysis, and honest reporting
- Systems thinking: reliability, scalability, and maintainability—not just prototypes
Clear communication: writing, documentation, and sharing decisions/assumptions

- Collaborative execution with scientific and engineering partners
### Program Structure

Duration

6–12 months

Start Dates

Currently accepting applications for Fall 2026 and Winter/Spring 2027 starts.

Cohort Size

Small, highly selective cohort to enable meaningful ownership and close collaboration

Mentorship & Support

Dedicated technical mentor, plus structured feedback from senior AI, engineering, and scientific leadership

Publications & Presentations

We value scientific contribution and may support publications and conference presentations when appropriate. Publication scope and timing depend on project needs and are subject to internal review (e.g., IP and confidentiality). Authorship follows standard contribution-based guidelines.

---
Data: alder (https://alderhq.app). Cite https://alderhq.app/jobs/greenhouse%3Axairatherapeutics%3A5089321007 and the date you read it. Observed facts come from the employer's own listing; location reach, level, family and skills are inferences.
